Checkpoint Blockade
Checkpoint Blockade - Related Videos
01:29
Neuromuscular Junction And Blockade
0 Views •
2025
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
08:50
Deep Neuromuscular Blockade Leads to a Larger Intraabdominal Volume During Laparoscopy
0 Views •
Cited by 49 •
2013
This article presents a method for measuring the working abdominal volume during laproscopic myomectomy using the surgical grasper, and applies this technique to obtain pilot data on whether deep neuromuscular blockade (NMB) can enable the use of lower insufflation pressure. Reduced insufflation pressure during laproscopic surgery has been shown to reduce post-operative pain, and thus the use of NMB during surgery may enable improved patient outcomes.
10:55
Study of the DNA Damage Checkpoint using Xenopus Egg Extracts
0 Views •
Cited by 35 •
2012
Xenopus egg extract is a useful model system to investigate the DNA damage checkpoint. This protocol is for the preparation of Xenopus egg extracts and DNA damage checkpoint inducing reagents. These techniques are adaptable to a variety of DNA damaging approaches in the study of the DNA damage checkpoint signaling.
02:19
The Spindle Assembly Checkpoint
0 Views •
2023
The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed. Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
02:19
The Spindle Assembly Checkpoint
0 Views •
2021
The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed. Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
FAQs
Blocking the PD-1 and PD-L1 interaction removes one inhibitory signal that can restrain T-cell activity. This allows previously limited immune responses to resume, supporting T-cell activation, proliferation, and effector function. The clinical significance is that antibody treatment can help immune cells respond more effectively against abnormal cells, particularly cancer cells expressing or affected by this regulatory pathway.
CTLA-4 represents a second inhibitory pathway targeted by checkpoint blockade. Antibodies can block CTLA-4 interactions with its ligands, reducing inhibitory control over immune activation. Because this pathway is distinct from PD-1 and PD-L1 signaling, identifying the specific checkpoint being targeted helps explain how different immune checkpoint inhibitor treatments restore T-cell function through separate regulatory interactions.
The same inhibitory pathways that limit harmful or excessive immune activity also restrain beneficial antitumor responses. Blocking them may therefore activate immune cells beyond the intended attack on abnormal cells, producing immune-related adverse events. This mechanism explains why treatment requires clinical monitoring and why adverse effects may need medical management rather than being viewed only as direct drug toxicity.
Restored T-cell activation, increased proliferation, and stronger effector function are the key cellular changes associated with effective checkpoint blockade. Together, these changes indicate that inhibitory signaling has been reduced enough for immune cells to respond more actively. In medicine, that response may translate into improved recognition and attack of abnormal cells, although durable benefit occurs only in some patients.
Cancer medicine uses antibody-based immune checkpoint inhibitor treatments to remove selected inhibitory signals from antitumor immune responses. The approach has become relevant across several cancers rather than being limited to one disease. Its purpose is to enable immune cells to recognize and attack abnormal cells, while clinical teams balance this potential benefit against the possibility of immune-related adverse events.
Evaluation centers on whether immune activity against abnormal cells produces a meaningful clinical response and whether that response persists. Checkpoint blockade can produce durable responses in some patients, making response longevity an important outcome in addition to initial tumor control. Assessment also includes monitoring for immune-related adverse events, since treatment benefit and excessive immune activation can occur together.